Discussion on: ``Is group testing ready for prime-time in disease identification?
From MaRDI portal
Publication:6628408
DOI10.1002/SIM.8988zbMATH Open1546.62101MaRDI QIDQ6628408
Could not fetch data.
Publication date: 29 October 2024
Published in: Statistics in Medicine (Search for Journal in Brave)
Cites Work
- Reader reaction: A note on the evaluation of group testing algorithms in the presence of misclassification
- Informative Dorfman Screening
- Group testing with a dilution effect
- Two‐Dimensional Informative Array Testing
- Informative Retesting
- Bayesian Methods for Predicting Interacting Protein Pairs Using Domain Information
- The objective function controversy for group testing: much ado about nothing?
- Optimal retesting configurations for hierarchical group testing
Related Items (2)
Estimating the prevalence of two or more diseases using outcomes from multiplex group testing ⋮ How could a pooled testing policy have performed in managing the early stages of the COVID-19 pandemic? Results from a simulation study
This page was built for publication: Discussion on: ``Is group testing ready for prime-time in disease identification?
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6628408)